Table of Contents Author Guidelines Submit a Manuscript
Pulmonary Medicine
Volume 2014, Article ID 782702, 8 pages
http://dx.doi.org/10.1155/2014/782702
Clinical Study

A Simple Clinical Measure of Quadriceps Muscle Strength Identifies Responders to Pulmonary Rehabilitation

1Queensland Lung Transplant Service, The Prince Charles Hospital, Rode Road, Chermside, QLD 4032, Australia
2School of Medicine, The University of Queensland, St Lucia, QLD 4072, Australia
3Physiotherapy Department, The Prince Charles Hospital, Rode Road, Chermside, QLD 4032, Australia
4School of Rehabilitation Sciences and Griffith Health Institute, Griffith University, Parklands Drive, Southport, QLD 4215, Australia
5Discipline of Physiotherapy, The University of Sydney, 75 East Street, Lidcombe, NSW 2141, Australia

Received 26 August 2013; Revised 8 November 2013; Accepted 12 November 2013; Published 30 January 2014

Academic Editor: Andrew Sandford

Copyright © 2014 James R. Walsh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Mannino and A. S. Buist, “Global burden of COPD: risk factors, prevalence, and future trends,” The Lancet, vol. 370, no. 9589, pp. 765–773, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Nici, C. Donner, E. Wouters et al., “American thoracic society/European respiratory society statement on pulmonary rehabilitation,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 12, pp. 1390–1413, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. L. Ries, G. S. Bauldoff, B. W. Carlin et al., “Pulmonary rehabilitation: joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines,” Chest, vol. 131, supplement 5, pp. 4S–42S, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Frith, J. Alison, J. Burdon et al., “Case Statement: Chronic Obstructive Pulmonary Disease (COPD): the Australian Lung Foundation,” 2001, http://www.lungfoundation.com.au/professional-resources/publications/copd-case-statements-2001-and-2002/.
  5. B. Vagaggini, F. Costa, S. Antonelli et al., “Clinical predictors of the efficacy of a pulmonary rehabilitation programme in patients with COPD,” Respiratory Medicine, vol. 103, no. 8, pp. 1224–1230, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Garrod, J. Marshall, E. Barley, and P. W. Jones, “Predictors of success and failure in pulmonary rehabilitation,” European Respiratory Journal, vol. 27, no. 4, pp. 788–794, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Troosters, R. Gosselink, and M. Decramer, “Exercise training in COPD: how to distinguish responders from nonresponders,” Journal of Cardiopulmonary Rehabilitation, vol. 21, no. 1, pp. 10–17, 2001. View at Google Scholar · View at Scopus
  8. C. Burtin, D. Saey, M. Saglam et al., “Effectiveness of exercise training in patients with COPD: the role of muscle fatigue,” European Respiratory Journal, vol. 40, no. 2, pp. 338–344, 2012. View at Publisher · View at Google Scholar
  9. L. Noreau and J. Vachon, “Comparison of three methods to assess muscular strength in individuals with spinal cord injury,” Spinal Cord, vol. 36, no. 10, pp. 716–723, 1998. View at Google Scholar · View at Scopus
  10. R. A. Evans, S. J. Singh, R. Collier, J. E. Williams, and M. D. L. Morgan, “Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade,” Respiratory Medicine, vol. 103, no. 7, pp. 1070–1075, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Crisafulli, S. Costi, F. Luppi et al., “Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation,” Thorax, vol. 63, no. 6, pp. 487–492, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Crisafulli, P. Gorgone, B. Vagaggini et al., “Efficacy of standard rehabilitation in COPD outpatients with comorbidities,” European Respiratory Journal, vol. 36, no. 5, pp. 1042–1048, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Yende, G. W. Waterer, E. A. Tolley et al., “Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects,” Thorax, vol. 61, no. 1, pp. 10–16, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Spruit, R. Gosselink, T. Troosters, A. Kasran, M. van Vliet, and M. Decramer, “Low-grade systemic inflammation and the response to exercise training in patients with advanced COPD,” Chest, vol. 128, no. 5, pp. 3183–3190, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. T. E. Dolmage, K. Hill, R. A. Evans, and R. S. Goldstein, “Has my patient responded? Interpreting clinical measurements such as the 6-minute-walk test,” American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 6, pp. 642–646, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Wanger, J. L. Clausen, A. Coates et al., “Standardisation of the measurement of lung volumes,” European Respiratory Journal, vol. 26, no. 3, pp. 511–522, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. J. G. W. Burdon, E. F. Juniper, and K. J. Killian, “The perception of breathlessness in asthma,” American Review of Respiratory Disease, vol. 126, no. 5, pp. 825–828, 1982. View at Google Scholar · View at Scopus
  18. A. D. Lopez, C. D. Mathers, M. Ezzati, D. T. Jamison, and C. J. L. Murray, “Measuring the global burden of disease and risk factors, 1990–2001,” in Global Burden of Disease and Risk Factors, A. D. Lopez, C. D. Mathers, M. Ezzati, D. T. Jamison, and C. J. L. Murray, Eds., World Bank, Washington, DC, USA, 2006. View at Google Scholar
  19. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories, “ATS statement: guidelines for the Six-Minute Walk Test,” American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 1, pp. 111–117, 2002. View at Publisher · View at Google Scholar
  20. J. E. A. Williams, S. J. Singh, L. Sewell, G. H. Guyatt, and M. D. L. Morgan, “Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR),” Thorax, vol. 56, no. 12, pp. 954–959, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. S. D. O'Shea, N. F. Taylor, and J. D. Paratz, “Measuring muscle strength for people with chronic obstructive pulmonary disease: retest reliability of hand-held dynamometry,” Archives of Physical Medicine and Rehabilitation, vol. 88, no. 1, pp. 32–36, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Watz, B. Waschki, T. Meyer, and H. Magnussen, “Physical activity in patients with COPD,” European Respiratory Journal, vol. 33, no. 2, pp. 262–272, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. E. Charlson, P. Pompei, K. A. Ales, and C. R. MacKenzie, “A new method of classifying prognostic comorbidity in longitudinal studies: development and validation,” Journal of Chronic Diseases, vol. 40, no. 5, pp. 373–383, 1987. View at Google Scholar · View at Scopus
  24. J. K. Wigal, T. L. Creer, and H. Kotses, “The COPD self-efficacy scale,” Chest, vol. 99, no. 5, pp. 1193–1196, 1991. View at Google Scholar · View at Scopus
  25. J. Alison, C. Barrack, P. Cafarella et al., “The Pulmonary Rehabilitation Toolkit on behalf of The Australian Lung Foundation,” 2009, http://www.pulmonaryrehab.com.au/welcome.asp.
  26. N. Luxton, J. A. Alison, J. Wu, and M. G. Mackey, “Relationship between field walking tests and incremental cycle ergometry in COPD,” Respirology, vol. 13, no. 6, pp. 856–862, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. E. Holland, C. J. Hill, T. Rasekaba, A. Lee, M. T. Naughton, and C. F. McDonald, “Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease,” Archives of Physical Medicine and Rehabilitation, vol. 91, no. 2, pp. 221–225, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. H. J. Schünemann, M. Puhan, R. Goldstein, R. Jaeschke, and G. H. Guyatt, “Measurement properties and interpretability of the Chronic Respiratory disease Questionnaire (CRQ),” Journal of Chronic Obstructive Pulmonary Disease, vol. 2, no. 1, pp. 81–89, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. R. A. Evans, S. J. Singh, R. Collier, J. E. Williams, and M. D. L. Morgan, “Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade,” Respiratory Medicine, vol. 103, no. 7, pp. 1070–1075, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease,” 2011, http://www.goldcopd.org/.
  31. M. A. Spruit, R. Gosselink, T. Troosters et al., “Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I,” Thorax, vol. 58, no. 9, pp. 752–756, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Augusti, L. D. Edwards, S. I. Rennard et al., “Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype,” PLos ONE, vol. 7, no. 5, Article ID e37483, 2012. View at Publisher · View at Google Scholar
  33. M. Thomsen, M. Dahl, P. Lange, J. Vestbo, and B. G. Nordestgaard, “Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 186, no. 10, pp. 982–988, 2012. View at Publisher · View at Google Scholar
  34. J. R. Walsh, Z. J. McKeough, N. R. Morris et al., “Metabolic disease and participant age are independent predictors of response to pulmonary rehabilitation,” Journal of Cardiopulmonary Rehabilitation and Prevention, vol. 33, no. 4, pp. 249–256. View at Publisher · View at Google Scholar